HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

AFL

Aflac Incorporated (S&P 500)

Financial Services — Insurance - Life

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

Hold 3.2 / 5 15 analysts
$111.18
$-0.60 (-0.54%)
Target: $118.53 (6.6%)

Price History

52-Week Range
Sign in to add AFL to a watchlist or set price alerts.

Fundamentals

Market Cap$55.74B
P/E Ratio (TTM)11.99
Forward P/E14.72
EPS (TTM)$9.27
Dividend Yield2.18%
Profit Margin26.91%
Revenue Growth-1.00%
ROE16.91%
Debt/Equity53.37
Recommendation Hold 3.2
Analyst Target$118.53
Analysts15
Next Earnings Nov 4, 2026 DMH
Indexes S&P 500

Technical Indicators

RSI (14)29.7
Beta0.58
SMA 20$115.12
SMA 40$117.14
52-Week High$130.22
52-Week Low$105.43
50-Day Avg$119.30
200-Day Avg$115.03
Avg Volume$2.06M
Volume$1.46M

Performance Analysis

BULLISH

AFL shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 23% of its 52-week range.
+ RSI at 29.7 signals oversold conditions — a bounce may be ahead.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 12.0 suggests the stock may be undervalued.
- Revenue declined 1.0% year-over-year.
+ Healthy profit margin of 26.9%.
~ Wall Street consensus is "Hold" from 15 analysts.
+ Average analyst target of $118.53 implies 6.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Oct 01, 2026 21:00 UTC

Back to Screener Export Report